Skip to main content
C

Charmacy Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 2289 HKEX Wholesale and retail trade
Open in API
Filings indexed 509 across all filing types
Latest filing 2025-05-22 Notice of Dividend Amou…
Country HK Hong Kong
Listing HKEX 2289

About Charmacy Pharmaceutical Co., Ltd.

http://www.chmyy.com

Charmacy Pharmaceutical Co., Ltd. is a leading pharmaceutical distribution company operating primarily in Southern China (Guangdong, Fujian, Guangxi, and Hainan). The core business involves distributing a comprehensive range of products, including Western medicines, Chinese patent medicines, and healthcare products, primarily targeting downstream distributors and retail terminal customers (chemists). The company specializes in the non-tender pharmaceutical market, where it holds a leading position. Additionally, Charmacy provides value-added services such as third-party logistics (3PL) and pharmaceutical product consultation, supported by modern distribution centers in key cities like Shantou, Guangzhou, and Shenzhen.

Recent filings

Filing Released Lang Actions
(UPDATED) FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024
Notice of Dividend Amount Classification · 1% confidence The document is a formal announcement of the final dividend for the year ended 31 December 2024, providing dividend rate, ex-dividend date, record date, payment date, and tax withholding details. This matches the definition of a Notice of Dividend Amount.
2025-05-22 English
ARTICLES OF ASSOCIATION
Governance Information Classification · 1% confidence The document is the full Articles of Association of Charmacy Pharmaceutical Co., Ltd., detailing the company’s internal rules, governance structures (general meetings, board of directors, supervisors, senior management), share capital provisions, amendment procedures, etc. This aligns exactly with the definition of Governance Information (Code: CGR). It is not an announcement or report of results, but the company’s constitutional governance document.
2025-05-22 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 22 MAY 2025&#x3b; AND DISTRIBUTION OF THE 2024 FINAL DIVIDEND
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document provides the poll results of the Annual General Meeting held on 22 May 2025 and related shareholder voting outcomes, together with details on the distribution of the final dividend. It is an announcement of voting results rather than the full annual report or financial statements, fitting the definition of ‘Declaration of Voting Results & Voting Rights Announcements’.
2025-05-22 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025
Regulatory Filings Classification · 1% confidence The document is a monthly compliance return (Form FF301) submitted to the Hong Kong Stock Exchange under Chapter 19B of the Listing Rules, detailing authorized, issued, and treasury share movements. It is not an announcement of a specific capital transaction or share issue, nor is it an annual or interim financial report; rather it is a routine regulatory filing required by the exchange. Therefore it falls under the general "Regulatory Filings" category (RNS).
2025-05-06 English
(UPDATED) FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024
Notice of Dividend Amount Classification · 1% confidence The document is an announcement titled “FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024” from Charmacy Pharmaceutical Co., Ltd., detailing the dividend type (final), amount per share, record/ex-dividend dates, book close period, payment date, and withholding tax information. This matches the definition of a Notice of Dividend Amount (Code: DIV), which covers announcements of dividend amounts, payment dates, and relevant details for shareholders.
2025-04-28 English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 22 MAY 2025 OR AT ANY ADJOURNMENT THEREOF
Proxy Solicitation & Information Statement Classification · 1% confidence The document is the form of proxy for the Annual General Meeting, used to solicit shareholder votes on resolutions. It is not the AGM presentation itself, nor the vote results, but rather materials sent to shareholders to request their vote. This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2025-04-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.